Transdermal bioidentical estradiol may carry a lower risk of clotting than oral forms because it avoids first-pass liver

https://www.inkitt.com/maultastus

Transdermal bioidentical estradiol may carry a lower risk of clotting than oral forms because it avoids first-pass liver metabolism, potentially making it preferable for some high-risk patients.